{
  "Q0": "BRCA1 and BRCA2 Targeted Variant Analysis - Ashkenazi Jewish Founder Variants",
  "Q1": "Yes",
  "Q2": "Not specified",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4_followup": {
    "match": "Yes",
    "guideline": "NCCN"
  },
  "Q5": "Not required",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q9_followup": {
    "match": "Yes"
  },
  "Q10": "No",
  "Q10_followup": [
    "Risk Assessment"
  ],
  "Q11": "Not specified",
  "Q12": "No",
  "Q13": "No",
  "Q14": "Yes",
  "Q14_followup": {
    "CPT_code": "81212"
  },
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "Submit the claim with the appropriate CPT code (81212) and ensure that the patient's Ashkenazi Jewish ancestry is documented, as this is a key factor for coverage under the policy.",
  "match": false
}